Abstract
Normal procalcitonin (PCT) levels have been reported in adult pulmonary tuberculosis (TB) but have not been previously investigated in children. We aimed to assess PCT levels at diagnosis of TB in young children in a low-burden setting. In a cross-sectional observational study in a referral pediatric center in Barcelona (Spain), we assessed the value of PCT and other inflammatory markers (leucocyte counts, C-reactive protein, and erythrocyte sedimentation rate) in the diagnosis of TB in pre-school children (< 6 years at diagnosis, n = 45), as compared with two control groups (pneumococcal pneumonia, n = 25; and healthy controls, n = 49). Normal PCT levels were observed at diagnosis of TB in most cases, while C-reactive protein values and leucocyte counts were slightly elevated when compared to healthy controls. All three inflammatory biomarkers were significantly higher in children with pneumococcal pneumonia.
Conclusions: In our study, PCT was not a useful diagnostic test for TB in young children. In a low-burden TB setting, PCT may be of some value in distinguishing pulmonary TB from pneumococcal pneumonia.
What is Known: • Diagnosis of pediatric tuberculosis on clinical evidence is difficult, particularly in infants and small children. • Studies in adults with tuberculosis have mostly reported normal procalcitonin levels at diagnosis. |
What is New: • In pre-scholars with tuberculosis, erythrocyte sedimentation rate and white blood cell counts were higher than in healthy controls, but procalcitonin was not. • Procalcitonin may be useful in the differential diagnosis of intrathoracic tuberculosis and pneumococcal pneumonia. |
Abbreviations
- BCG:
-
Bacillus Calmette-Guérin
- CAP:
-
Community-acquired pneumonia
- CRP:
-
C-reactive protein
- ESR:
-
Erythrocyte sedimentation rate
- IFN-γ:
-
Interferon-γ
- IQR:
-
Interquartile range
- MTB:
-
Mycobacterium tuberculosis
- PCT:
-
Procalcitonin
- QFT-GIT:
-
QuantiFERON-TB Gold In-Tube
- TST:
-
Tuberculin skin test
- TB:
-
Tuberculosis
- WBC:
-
White blood cell
References
Davies J (2015) Procalcitonin. J Clin Pathol 368:675–679
Díez-Padrisa N, Bassat Q, Machevo S, Quintó L, Morais L, Nhampossa T, O'Callaghan-Gordo C, Torres A, Alonso PL, Roca A (2010) Procalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area. PLoS One 5(10):e13226. https://doi.org/10.1371/journal.pone.0013226
Galetto-Lacour A, Alcoba G, Posfay-Barbe KM, Cevey-Macherel M, Gehri M, Ochs MM, Brookes RH, Siegrist CA, Gervaix A (2013) Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children. Pediatr Infect Dis J 32(11):1175–1179. https://doi.org/10.1097/INF.0b013e31829ba62a
Giulia B, Luisa A, Concetta S, Bruna LS, Chiara B, Marcello C (2015) Procalcitonin and community-acquired pneumonia (CAP) in children. Clin Chim Acta 451:215–218. https://doi.org/10.1016/j.cca.2015.09.031
Graham SM, Ahmed T, Amanullah F, Browning R, Cardenas V, Casenghi M, Cuevas LE, Gale M, Gie RP, Grzemska M, Handelsman E, Hatherill M, Hesseling AC, Jean-Philippe P, Kampmann B, Kabra SK, Lienhardt C, Lighter-Fisher J, Madhi S, Makhene M, Marais BJ, McNeeley DF, Menzies H, Mitchell C, Modi S, Mofenson L, Musoke P, Nachman S, Powell C, Rigaud M, Rouzier V, Starke JR, Swaminathan S, Wingfield C (2012) Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease Consensus from an expert panel. J Infect Dis 205(Suppl.2):S199–2208
Huang SL, Lee HC, Yu CW, Chen HC, Wang CC, Wu JY, Lee CC (2014) Value of procalcitonin in differentiating pulmonary tuberculosis from other pulmonary infections: a meta-analysis. Int J Tuberc Lung Dis 18(4):470–477. https://doi.org/10.5588/ijtld.13.0449
Huang CT, Lee LN, Ho CC, Shu CC, Ruan SY, Tsai YJ, Wang JY, Yu CJ (2014) High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis. J Inf Secur 68:440–447
Nyamande K, Lalloo UG (2006) Serum procalcitonin distinguishes CAP due to bacteria, mycobacterium tuberculosis and PJP. Int J Tuberc Lung Dis 10(5):510–515
Oliwa JN, Karumbi JM, Marais BJ, Madhi SA, Graham SM (2015) Tuberculosis as a cause or comorbidity of childhood pneumonia in tuberculosis-endemic areas: a systematic review. Lancet Respir Med 3(3):235–243. https://doi.org/10.1016/S2213-2600(15)00028-4
Pierce R, Bigham MT, Giuliano JS Jr (2014) Use of procalcitonin for the prediction and treatment of acute bacterial infection in children. Curr Opin Pediatr 26(3):292–298. https://doi.org/10.1097/MOP.0000000000000092
Ugajin M, Miwa S, Shirai M, Ohba H, Eifuku T, Nakamura H, Suda T, Hayakawa H, Chida K (2011) Usefulness of serum procalcitonin levels in pulmonary tuberculosis. Eur Respir J 37:371–375
Vekemans J, Amedei A, Ota MO, D'Elios MM, Goetghebuer T, Ismaili J, Newport MJ, Del Prete G, Goldman M, McAdam KP, Marchant A (2001) Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 31(5):1531–1535. https://doi.org/10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1
Wiseman CA, Gie RP, Starke JR, Schaaf HS, Donald PR, Cotton MF, Hesseling AC (2012) A proposed comprehensive classification of tuberculosis disease severity in children. Pediatr Infect Dis J 31(4):347–352. https://doi.org/10.1097/INF.0b013e318243e27b
Acknowledgements
We are indebted to the “Biobanc de l’Hospital Infantil Sant Joan de Déu per a la Investigació,” a member of the ISCIII National Network of Biobanks, for sample and data procurement.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
EVA, EP, CF, and ANJ designed the study. DH, AV, and PB developed the methodology. EVA, EP, DH, AFL, and CF collected the data. EVA and ANJ performed the analysis and wrote the first draft of the manuscript. All authors saw, approved, and take full responsibility for the final version of the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent for publication
Informed consent was obtained from all individual participants included in the study.
Additional information
Communicated by Nicole Ritz
Rights and permissions
About this article
Cite this article
Velasco-Arnaiz, E., Pérez, E., Henares, D. et al. Use of procalcitonin in the diagnosis of tuberculosis in infants and preschool children . Eur J Pediatr 177, 1377–1381 (2018). https://doi.org/10.1007/s00431-018-3099-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-018-3099-9